FDA
-
-
-
-
-
-
-
Cerus names Vivek Jayaraman as CEO effective July 2026
-
-
-
-
-
-
-
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook
-
-
-
-
-
-
-
The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions
-
-
-
-
-
-
-
Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update
-
-
-
-
-
-
-
Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device
-
-
-
-
-
-
-
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update
-
-
-
-
-
-
-
Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range
-
322,850 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

